Literature DB >> 33817272

Relationship of FTO gene variations with NAFLD risk in Chinese men.

Xuefen Chen1, Yong Gao2, Xiaobo Yang2, Haiying Zhang2, Zengnan Mo2, Aihua Tan1.   

Abstract

BACKGROUND: Fat mass and obesity-associated (FTO) gene is an obesity susceptibility gene and its relationship with the nonalcoholic fatty liver disease (NAFLD) remains unclear. This study aims to investigate the relationships of FTO gene variations with NAFLD risk in a Chinese male population.
METHODS: A 1:2 matched case-control study was performed on 275 cases of NAFLD and 550 controls matched for age. Nine of the FTO gene single nucleotide polymorphisms (SNPs) were genotyped.
RESULTS: Logistic regression analysis found that FTO rs1477196 was significantly associated with the susceptibility to NAFLD in recessive genetic models [unadjusted odds ratio (OR) = 2.52, 95% confidence interval (CI): 1.22-5.19, P = 0.012] and the relativity weakened after further adjustment for body mass index (BMI), uric acid, metabolic syndrome, smoking, and drinking (adjusted OR = 2.18, 95% CI: 0.96-4.99, P = 0.06). In the obese group, the AA + AG genotypes of rs1121980 and rs9940128 were associated with a decreased risk of NAFLD, when compared with the GG genotype, respectively (rs1121980: adjusted OR = 0.62, 95% CI = 0.39-0.99, P = 0.044; rs9940128: adjusted OR = 0.61, 95% CI = 0.38-0.97, P = 0.038). Furthermore, rs1477196 was associated with the severity of NAFLD (OR = 2.95, 95% CI = 1.09-7.94, P = 0.034).
CONCLUSIONS: Our results demonstrated that the FTO gene was related to the presence and severity of NAFLD in a Chinese male population, and the relationships of the tested SNPs with NAFLD are most probably mediated by BMI.
© 2020 Xuefen Chen et al., published by De Gruyter.

Entities:  

Keywords:  FTO gene; SNPs; nonalcoholic fatty liver disease; obesity

Year:  2020        PMID: 33817272      PMCID: PMC7874577          DOI: 10.1515/biol-2020-0081

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  30 in total

1.  Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study.

Authors:  Ron Do; Swneke D Bailey; Katia Desbiens; Alexandre Belisle; Alexandre Montpetit; Claude Bouchard; Louis Pérusse; Marie-Claude Vohl; James C Engert
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

2.  FTO risk haplotype among early onset and severe obesity cases in a population of western Spain.

Authors:  Juan R González; Marta González-Carpio; Rosario Hernández-Sáez; Victoria Serrano Vargas; Guadalupe Torres Hidalgo; Marta Rubio-Rodrigo; Ana García-Nogales; Manuela Núñez Estévez; Luis M Luengo Pérez; Raquel Rodríguez-López
Journal:  Obesity (Silver Spring)       Date:  2011-10-27       Impact factor: 5.002

3.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

4.  A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population.

Authors:  Aihua Tan; Jielin Sun; Ning Xia; Xue Qin; Yanling Hu; Shijun Zhang; Sha Tao; Yong Gao; Xiaobo Yang; Haiying Zhang; Seong-Tae Kim; Tao Peng; Xiaoling Lin; Li Li; Linjian Mo; Zhengjia Liang; Deyi Shi; Zhang Huang; Xianghua Huang; Ming Liu; Qiang Ding; Jeffrey M Trent; S Lilly Zheng; Zengnan Mo; Jianfeng Xu
Journal:  Hum Mol Genet       Date:  2011-12-14       Impact factor: 6.150

5.  The Frequencies of Haplotypes of FTO Gene Variants and Their Association with the Distribution of Body Fat in Non-Obese Poles.

Authors:  Katarzyna Kolačkov; Łukasz Łaczmański; Felicja Lwow; David Ramsey; Aleksandra Zdrojowy-Wełna; Małgorzata Tupikowska; Grażyna Bednarek-Tupikowska
Journal:  Adv Clin Exp Med       Date:  2016 Jan-Feb       Impact factor: 1.727

6.  Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.

Authors:  Xiaoliang Wang; Zhipeng Liu; Kai Wang; Zhaowen Wang; Xing Sun; Lin Zhong; Guilong Deng; Guohe Song; Baining Sun; Zhihai Peng; Wanqing Liu
Journal:  Front Genet       Date:  2016-08-02       Impact factor: 4.599

7.  Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population.

Authors:  Hui Li; Yanzhen Chen; Xing Tian; Yu Hong; Chengliang Chen; Nawaz Khukhar Sharokh; Jian Jiao
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-08-06

8.  Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study.

Authors:  Rosa Reddavide; Anna Maria Cisternino; Rosa Inguaggiato; Ornella Rotolo; Iris Zinzi; Nicola Veronese; Vito Guerra; Fabio Fucilli; Giuseppe Di Giovanni; Gioacchino Leandro; Sara Giannico; Maria Gabriella Caruso
Journal:  Nutrients       Date:  2019-08-07       Impact factor: 5.717

9.  Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China.

Authors:  Jun-Jie Liu; Yuan-Yuan Chen; Zeng-Nan Mo; Gui-Xiang Tian; Ai-Hua Tan; Yong Gao; Xiao-Bo Yang; Hai-Ying Zhang; Zhi-Xian Li
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

10.  Influence of FTO variants on obesity, inflammation and cardiovascular disease risk biomarkers in Spanish children: a case-control multicentre study.

Authors:  Josune Olza; Azahara I Ruperez; Mercedes Gil-Campos; Rosaura Leis; Dietmar Fernandez-Orth; Rafael Tojo; Ramon Cañete; Angel Gil; Concepcion M Aguilera
Journal:  BMC Med Genet       Date:  2013-12-01       Impact factor: 2.103

View more
  2 in total

1.  Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.

Authors:  Lidan Cheng; Peng Yu; Fangfang Li; Xueling Jiang; Xiaojuan Jiao; Yunfeng Shen; Xiaoyang Lai
Journal:  Hum Cell       Date:  2021-08-19       Impact factor: 4.174

2.  Gut microbiota modulates differential lipid metabolism outcomes associated with FTO gene polymorphisms in response to personalized nutrition intervention.

Authors:  Jianheng Zheng; Feijie Wang; Hongwei Guo; Junrui Cheng; Jun Du; Juntao Kan
Journal:  Front Nutr       Date:  2022-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.